SLC22A16 and breast carcinoma: Expression of ABCB1, ABCC2, ABCG2, SLC22A16, and SLCO1A2 was significantly higher in normal breast tissue compared to tumorous tissue, while SLC22A1 and the tumor marker ESR1 showed a significantly higher expression in breast cancer tissue.